Contact
searchSearch
HMP Global
Login

Journal of Clinical Pathways

Featured

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
EVOLUTION OF PATHWAYS
A Decade of Progress: The Evolution of Clinical Pathways and the Role of the Journal of Clinical Pathways in Advancing Value-Based Cancer Care
02/18/2025
Winston Wong, PharmD; Gordon Kuntz
The Journal of Clinical Pathways reflects on 10 years of clinical pathways evolution in oncology care, from treatment sequencing to a vital tool for navigating value-based cancer care.
The Journal of Clinical Pathways reflects on 10 years of clinical pathways evolution in oncology care, from treatment sequencing to a vital tool for navigating value-based cancer care.
The Journal of Clinical Pathways...
02/18/2025
Journal of Clinical Pathways
Perspectives
Taking the Garbage Out: Addressing AI Bias in Quality Measurement
12/02/2024
Maggie Dietrick, MPH; Palak Patel, MHA; Tom Valuck, MD, JD
This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.
This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.
This article explores the use of...
12/02/2024
Journal of Clinical Pathways
Editor's Page
Solutions for a Broken Health Care System
10/02/2024
Winston Wong, PharmD
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including critical issues in the health care system, emphasizing the need for innovative solutions to improve accessibility, affordability, and quality of care.
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including critical issues in the health care system, emphasizing the need for innovative solutions to improve accessibility, affordability, and quality of care.
Editor-in-Chief Winston Wong,...
10/02/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Managing Clinical & Financial Risk in Oncology
09/13/2024
Grace Taylor, MS, MA
A group of oncology practice innovators and care platform disruptors spoke about managing clinical and financial risk in oncology as part of a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
A group of oncology practice innovators and care platform disruptors spoke about managing clinical and financial risk in oncology as part of a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
A group of oncology practice...
09/13/2024
Journal of Clinical Pathways
News
Study Examines Impact of Vial Sizes on Drug Waste of Multiple Myeloma Treatment
09/06/2024
Grace Taylor, MS, MA
Researchers looked at the impact of vial sizes on drug waste and cost when using bortezomib and carfilzomib to treat patients with multiple myeloma.
Researchers looked at the impact of vial sizes on drug waste and cost when using bortezomib and carfilzomib to treat patients with multiple myeloma.
Researchers looked at the impact...
09/06/2024
Journal of Clinical Pathways
Luke Pike, MD
Videos
Evaluating Stereotactic Radio Surgery Plus TKI Vs TKI Alone Among Patients With Brain Metastases from EGFR- and ALK-Altered NSCLC (Part I)
09/05/2024
Luke R.G. Pike, MD, PhD
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Luke Pike, MD, breaks down the...
09/05/2024
Journal of Clinical Pathways
Sawsan Rashdan, MD
Videos
Safety and Efficacy of Osimertinib Plus Consolidative Stereotactic Ablative Radiation in Patients With Advanced EGFR Mutant NSCLC
08/28/2024
Sawsan Rashdan, MD
Sawsan Rashdan, MD, shares the main findings from her study on the use of osimertinib plus consolidative stereotactic ablative radiation for treating patients with advanced EGFR-mutated non–small cell lung cancer (NSCLC).
Sawsan Rashdan, MD, shares the main findings from her study on the use of osimertinib plus consolidative stereotactic ablative radiation for treating patients with advanced EGFR-mutated non–small cell lung cancer (NSCLC).
Sawsan Rashdan, MD, shares the...
08/28/2024
Journal of Clinical Pathways
Matthew Cortese, MD
Videos
Treatment Options for Chronic Lymphocytic Leukemia Beyond Chemotherapy
08/26/2024
Matthew Cortese, MD, MPH
Matthew Cortese, MD, discusses recent updates in the National Comprehensive Cancer Network guidelines for the treatment of chronic lymphocytic leukemia (CLL) and ongoing clinical trials in this space.
Matthew Cortese, MD, discusses recent updates in the National Comprehensive Cancer Network guidelines for the treatment of chronic lymphocytic leukemia (CLL) and ongoing clinical trials in this space.
Matthew Cortese, MD, discusses...
08/26/2024
Journal of Clinical Pathways

From the Journal

Perspectives
Taking the Garbage Out: Addressing AI Bias in Quality Measurement
12/02/2024
Maggie Dietrick, MPH; Palak Patel, MHA; Tom Valuck, MD, JD
This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.
This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.
This article explores the use of...
12/02/2024
Journal of Clinical Pathways
From the Field
Cost and Clinical Implications of Utilizing Homologous Recombination Deficiency Status to Guide First-Line Maintenance Therapy Selection in Advanced Ovarian Cancer
12/02/2024
Daniel Simmons, PharmD, MS; Rebecca Stone, MD; James Ryan, MSc; Jigna Bhalla, PharmD; Kimmie McLaurin, MS
This study models the clinical outcomes and costs associated with utilizing an HRD biomarker-guided (BMG) approach to first-line AOC maintenance compared with a non-biomarker-guided (NBMG) approach.
This study models the clinical outcomes and costs associated with utilizing an HRD biomarker-guided (BMG) approach to first-line AOC maintenance compared with a non-biomarker-guided (NBMG) approach.
This study models the clinical...
12/02/2024
Journal of Clinical Pathways
Perspectives
Facing Cancer as a Chronic Disease: Shared Decision-Making at Critical Points in a Long Illness Journey
10/01/2024
Christine M. Wilson, MS; Gwen Darien; Kathleen D. Gallagher, MPH; Alan J. Balch, PhD, MSc
In this third installment of a three-part series on decision support tools and shared decision-making, Christine Wilson, MA, MS, and colleagues describe how patients with­in three diverse communities who are living with cancer understand and...
In this third installment of a three-part series on decision support tools and shared decision-making, Christine Wilson, MA, MS, and colleagues describe how patients with­in three diverse communities who are living with cancer understand and...
In this third installment of a...
10/01/2024
Journal of Clinical Pathways
Perspectives
Who Uses Pathways Around Care Management?
10/01/2024
Sheryl Riley, RN, OCN, CMCN; F. Randy Vogenberg, PhD, FASHP
This pilot study provides a brief literature review on users, uses, and a recent electronic survey to de­termine how users use clinical pathways along with their feedback around their value.
This pilot study provides a brief literature review on users, uses, and a recent electronic survey to de­termine how users use clinical pathways along with their feedback around their value.
This pilot study provides a...
10/01/2024
Journal of Clinical Pathways
Research Reports
Time to Treatment and the “Golden Hour”: Why They Matter and How Clinical Pathways Can Help
08/19/2024
Dennis R. Holmes, MD, FACS; Juvairiya Pulicharam, MD; Steven Evans, MD
This study explores how clinical pathways can help reduce time to treatment delays while improving health care quality, lowering direct and indirect health care costs, reducing patient financial toxicity, and achieving greater patient,...
This study explores how clinical pathways can help reduce time to treatment delays while improving health care quality, lowering direct and indirect health care costs, reducing patient financial toxicity, and achieving greater patient,...
This study explores how clinical...
08/19/2024
Journal of Clinical Pathways
From the Field
Bridging the Gap Between Oncologists and Payers: Impact of an EHR-Embedded CDS Tool in Oncology Clinical Pathway (OCP) Adherence
08/15/2024
Anna Bolha, MPAS, PA; Rebecca Maniago, PharmD, BCOP; Nina Sardesh; Taylor Dias-Foundas; James Roose, MA; Colin Harvey; Marcello Ricottone; Eric Weber; Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC; Brian Patrick Mulherin, MD; Andrew Hertler, MD, FACP; James Hamrick, MD, MPH
In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...
In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...
In this report, researchers...
08/15/2024
Journal of Clinical Pathways
Perspectives
Individualized Care Through Treatment Pathways: Isn’t This an Oxymoron?
06/26/2024
Ray Page, DO, PhD, FACOI, FASCO
This article describes how congruent solutions for treatment options can be achieved if the objectives of precision medicine and treatment pathways are aligned.
This article describes how congruent solutions for treatment options can be achieved if the objectives of precision medicine and treatment pathways are aligned.
This article describes how...
06/26/2024
Journal of Clinical Pathways
From the Field
Shifting the Paradigm: The Impact of AI at the Point of Care in Cancer Treatment
06/03/2024
Taylor Dias-Foundas
This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.
This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.
This report explores the...
06/03/2024
Journal of Clinical Pathways
Research Reports
PSA Outcomes and Clinical Surveillance Among Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With a Next-Generation Androgen Receptor Inhibitor in Urology Practices With or Without In-Office Dispensing
06/03/2024
This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...
This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...
This study describes...
06/03/2024
Journal of Clinical Pathways
From the Field
Bringing Value to Health Care
06/03/2024
Lili Brillstein, MPH
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
This paper provides insights and...
06/03/2024
Journal of Clinical Pathways

Guideline Updates

Deborah Stephens, DO, University of Utah
Videos
Overview of the Updated NCCN Guidelines on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
05/17/2023
Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...
Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...
Deborah Stephens, DO, Huntsman...
05/17/2023
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Clinical Practice Guidelines for Multiple Myeloma
01/11/2023
Yvette C. Terrie, BS Pharm, RPh
The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...
The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...
The NCCN recently published...
01/11/2023
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Clinical Practice Guidelines in Thyroid Carcinoma
09/08/2022
Yvette C. Terrie, BS Pharm, RPh
The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.
The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.
The National Comprehensive...
09/08/2022
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Therapy Guidelines in Bladder Cancer
08/26/2022
Yvette C. Terrie, BS Pharm, RPh
NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.
NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.
NCCN Guidelines Panel for...
08/26/2022
Journal of Clinical Pathways

Videos

Videos
Why Pathways Matter: Editorial Advisory Board Testimonials
03/24/2025
F. Randy Vogenberg, PhD, FASHP
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal...
03/24/2025
Journal of Clinical Pathways
Videos
Progress and Unmet Needs in Post-IO Treatment for Metastatic RCC
03/19/2025
Neil Shah, MD
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah...
03/19/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 2
03/17/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology...
03/17/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 1
03/11/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this interview, experts Gordon Kuntz and Carole Tremonti, RN, MBA, discuss the goals, challenges, and collaborative efforts of the Predictable Cost of Care Working Group, highlighting its role in developing a standardized model for...
In this interview, experts Gordon Kuntz and Carole Tremonti, RN, MBA, discuss the goals, challenges, and collaborative efforts of the Predictable Cost of Care Working Group, highlighting its role in developing a standardized model for...
In this interview, experts...
03/11/2025
Journal of Clinical Pathways
Zibelman Headshot
Videos
Exploring the Potential of Nivolumab and Axitinib in Renal Cell Carcinoma
03/11/2025
Matthew Zibelman, MD
Matthew Zibelman, MD, shares results from his study on combination systemic therapy with tyrosine kinase inhibitor nivolumab and immune checkpoint inhibitor axitinib for patients with metastatic renal cell carcinoma.
Matthew Zibelman, MD, shares results from his study on combination systemic therapy with tyrosine kinase inhibitor nivolumab and immune checkpoint inhibitor axitinib for patients with metastatic renal cell carcinoma.
Matthew Zibelman, MD, shares...
03/11/2025
Journal of Clinical Pathways
BDHC Thumbnail
Videos
Expanding Access to Clinical Trials: What Oncologists and Payers Need to Know
02/28/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down...
02/28/2025
Cancer Care Business Exchange
Videos
Why Pathways Matter: Editorial Advisory Board Testimonials
02/28/2025
Alan J. Balch, PhD, MSc
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal...
02/28/2025
Journal of Clinical Pathways
Doshi Headshot
Videos
Assessing Real-World Outcomes of First-Line Ipilimumab and Nivolumab for Advanced Renal Cell Carcinoma
02/18/2025
Sahil Doshi, MD
In this interview, Sahil Doshi, MD, discusses the outcomes of a recent trial he authored on first-line ipilimumab and nivolumab for metastatic renal cell carcinoma, highlighting its implications for clinical practice and payer considerations.
In this interview, Sahil Doshi, MD, discusses the outcomes of a recent trial he authored on first-line ipilimumab and nivolumab for metastatic renal cell carcinoma, highlighting its implications for clinical practice and payer considerations.
In this interview, Sahil Doshi,...
02/18/2025
Journal of Clinical Pathways
Headshot
Videos
The Role of ctDNA Clearance in RCC: Retrospective Analysis and Clinical Implications
02/13/2025
Adanma Ayanambakkam, MD
In this interview, Adanma Ayanambakkam, MD, discusses his study on the use of circulating tumor DNA (ctDNA) clearance as a biomarker in renal cell carcinoma (RCC), highlighting findings from a single-institution retrospective study and its...
In this interview, Adanma Ayanambakkam, MD, discusses his study on the use of circulating tumor DNA (ctDNA) clearance as a biomarker in renal cell carcinoma (RCC), highlighting findings from a single-institution retrospective study and its...
In this interview, Adanma...
02/13/2025
Journal of Clinical Pathways
Houda Hachad, PharmD
Videos
Implementing PGx Testing in Oncology: Best Practices, Barriers, and Benefits
02/12/2025
Houda Hachad, PharmD
Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.
Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.
Houda Hachad, PharmD, highlights...
02/12/2025
Journal of Clinical Pathways

Features

Original Research
An Oncology Provider-Driven Model to Implement Germline Genetic Testing Among Diverse Patients With Advanced Prostate Cancer
02/18/2025
Lisa Nuccio, MSN, FNP-C; Kirsten Drabek, BS; Neha Hippalgaonkar, MD; Aseem Tiwari, MPH, MD, MBBS; Vivian Pan, MS, PhD; Kent Hoskins, MD; Pamela Ganschow, MD; Tara Maga, PhD, MS; Lara Balay, MS Ed, MS, CGC; Karine Tawagi, MD; Natalie Reizine, MD
In this study, researchers examine the clinical implementation of an oncology-directed model of delivering guideline-concordant germline genetic testing in patients living with and receiving standard-of-care treatment for advanced prostate...
In this study, researchers examine the clinical implementation of an oncology-directed model of delivering guideline-concordant germline genetic testing in patients living with and receiving standard-of-care treatment for advanced prostate...
In this study, researchers...
02/18/2025
Journal of Clinical Pathways
Original Research
Comparison of Specialty Injection and Infusion Adverse Events Among Hospital Outpatient Settings vs Non-Hospital Outpatient Settings
02/18/2025
Lavanya Raj, MBBS, MS; Gentri Stinson, BSN, MSN, APRN; Jeffrey W. Langsam, DO; Julie DeMacio, RN, BSN
This study analyzes the clinical outcomes associated with Cigna Healthcare’s site-of-care management strategies that redirect injected and infused specialty medications from high-cost hospital outpatient setting or out-of-network providers to...
This study analyzes the clinical outcomes associated with Cigna Healthcare’s site-of-care management strategies that redirect injected and infused specialty medications from high-cost hospital outpatient setting or out-of-network providers to...
This study analyzes the clinical...
02/18/2025
Journal of Clinical Pathways
Perspectives
Taking the Garbage Out: Addressing AI Bias in Quality Measurement
12/02/2024
Maggie Dietrick, MPH; Palak Patel, MHA; Tom Valuck, MD, JD
This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.
This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.
This article explores the use of...
12/02/2024
Journal of Clinical Pathways
Case Study
Development and Analysis of a Treatment Timeliness Dashboard for Patients With Head and Neck Cancer at a Tertiary Academic Multidisciplinary Clinic
12/02/2024
Martha J. Ryan, MSN, FNP-C; Melissa F. Riedel, MPH; Karoline Fendley, BSN, RN; Nicole C. Schmitt, MD; Mark W. El-Deiry, MD
In this case study, researchers describe a treatment timeline dashboard for treating patients with head and neck cancer using a primary nursing care coordination model.
In this case study, researchers describe a treatment timeline dashboard for treating patients with head and neck cancer using a primary nursing care coordination model.
In this case study, researchers...
12/02/2024
Journal of Clinical Pathways
From the Field
Cost and Clinical Implications of Utilizing Homologous Recombination Deficiency Status to Guide First-Line Maintenance Therapy Selection in Advanced Ovarian Cancer
12/02/2024
Daniel Simmons, PharmD, MS; Rebecca Stone, MD; James Ryan, MSc; Jigna Bhalla, PharmD; Kimmie McLaurin, MS
This study models the clinical outcomes and costs associated with utilizing an HRD biomarker-guided (BMG) approach to first-line AOC maintenance compared with a non-biomarker-guided (NBMG) approach.
This study models the clinical outcomes and costs associated with utilizing an HRD biomarker-guided (BMG) approach to first-line AOC maintenance compared with a non-biomarker-guided (NBMG) approach.
This study models the clinical...
12/02/2024
Journal of Clinical Pathways

Columns

COA Viewpoint
The Crucial Role of the States in Advancing Cancer Care Policy in the US
02/18/2025
James Lee
This column explores how state-level initiatives and policies are pivotal in enhancing cancer care across the US and how advocates can learn from the battles of 2024 to prepare themselves for 2025’s legislative sessions.
This column explores how state-level initiatives and policies are pivotal in enhancing cancer care across the US and how advocates can learn from the battles of 2024 to prepare themselves for 2025’s legislative sessions.
This column explores how...
02/18/2025
Journal of Clinical Pathways
Letter from the Editor
Embracing Change and Advancing Innovation: A Transformative Start to 2025
02/18/2025
Winston Wong, PharmD
This issue of Journal of Clinical Pathways explores the evolving landscape of health care in 2025, highlighting rising costs, the growing impact of provider-driven oncology models, and the transformation of clinical pathways in value-based...
This issue of Journal of Clinical Pathways explores the evolving landscape of health care in 2025, highlighting rising costs, the growing impact of provider-driven oncology models, and the transformation of clinical pathways in value-based...
This issue of Journal of...
02/18/2025
Journal of Clinical Pathways
MAI Mindset
Clearing the Air: Exploring Payer Pathway Breadth and Depth
02/18/2025
Daniel Buchenberger, MS
This entry of our MAI Mindset column highlights key findings from HMP Market Access Insights' latest research on the values, structures, and processes driving payer- and provider-developed clinical pathway programs.
This entry of our MAI Mindset column highlights key findings from HMP Market Access Insights' latest research on the values, structures, and processes driving payer- and provider-developed clinical pathway programs.
This entry of our MAI Mindset...
02/18/2025
Journal of Clinical Pathways
Editor's Page
Closing Out 2024: Advancing Value-Based Oncology Through Innovation and Equity
12/02/2024
Winston Wong, PharmD
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including reducing artificial intelligence-driven bias, the impact of the 340B program in the commercial employer market, and the cost-effectiveness of...
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including reducing artificial intelligence-driven bias, the impact of the 340B program in the commercial employer market, and the cost-effectiveness of...
Editor-in-Chief Winston Wong,...
12/02/2024
Journal of Clinical Pathways
MAI Mindset
Oncology Pathways Research: Challenges, Adoption, and Future Trends
12/02/2024
Cindy Chen, MBA
In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research.
In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research.
In an exclusive interview with...
12/02/2024
Journal of Clinical Pathways

Departments

Conference Highlights
Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams
12/02/2024
Shaffee Bacchus, PharmD
In this exclusive interview, Dr Bacchus highlights the evolution of treatment for chronic lymphocytic leukemia (CLL) and provides context regarding the complex needs of patients with CLL.
In this exclusive interview, Dr Bacchus highlights the evolution of treatment for chronic lymphocytic leukemia (CLL) and provides context regarding the complex needs of patients with CLL.
In this exclusive interview, Dr...
12/02/2024
Journal of Clinical Pathways
Conference Highlights
Highlights From the 65th ASH Annual Meeting & Exposition
02/09/2024
The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...
The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...
The American Society of...
02/09/2024
Journal of Clinical Pathways
Conference Highlights
Key Highlights From CPC+CBEx 2023
12/14/2023
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress +...
12/14/2023
Journal of Clinical Pathways
Corrigendum
Corrigendum: The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences
12/14/2023
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the...
12/14/2023
Journal of Clinical Pathways
Clinical Pathways Forum
Beyond Adherence: Clinical Pathways at Roswell Park
12/13/2023
Mishellene McKinney, MHA, RN, OCN
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical...
12/13/2023
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Recent Stories

Conference Coverage
Delayed EGFR Testing in Early-Stage NSCLC Linked to Increased Health Care Utilization and Cost Burden
04/01/2025
Juliet Gallagher
Timely molecular testing is essential for guiding targeted treatment in patients with early-stage non-small cell lung cancer (eNSCLC), particularly those with EGFR mutations. Findings presented at the 2025 National Comprehensive Cancer...
Timely molecular testing is essential for guiding targeted treatment in patients with early-stage non-small cell lung cancer (eNSCLC), particularly those with EGFR mutations. Findings presented at the 2025 National Comprehensive Cancer...
Timely molecular testing is...
04/01/2025
Journal of Clinical Pathways
Conference Coverage
Study Explores Early Palliative Care Referral Patterns and Outcomes in SCLC
04/01/2025
Juliet Gallagher
At the 2025 National Comprehensive Cancer Network (NCCN) Annual Conference, researchers presented findings from a retrospective study evaluating timing of palliative care referral and associated outcomes among patients with small cell lung...
At the 2025 National Comprehensive Cancer Network (NCCN) Annual Conference, researchers presented findings from a retrospective study evaluating timing of palliative care referral and associated outcomes among patients with small cell lung...
At the 2025 National...
04/01/2025
Journal of Clinical Pathways
Conference Coverage
EHR-Embedded CDS Tool Enhances Specialty Drug Management in Oncology
03/28/2025
Juliet Gallagher
A retrospective study presented at the 2025 National Comprehensive Cancer Network (NCCN) Annual Conference evaluated how embedding a clinical decision support (CDS) tool within the electronic health record (EHR) can enhance specialty drug...
A retrospective study presented at the 2025 National Comprehensive Cancer Network (NCCN) Annual Conference evaluated how embedding a clinical decision support (CDS) tool within the electronic health record (EHR) can enhance specialty drug...
A retrospective study presented...
03/28/2025
Journal of Clinical Pathways
Conference Coverage
Patient-Centered Insights into Treatment Preferences for Locally Advanced and Metastatic NSCLC
03/28/2025
Juliet Gallagher
New research presented at the 2025 National Comprehensive Cancer Network (NCCN) Annual Conference sheds light on how patients with advanced or metastatic non-small cell lung cancer (aNSCLC or mNSCLC) approach treatment decision-making,...
New research presented at the 2025 National Comprehensive Cancer Network (NCCN) Annual Conference sheds light on how patients with advanced or metastatic non-small cell lung cancer (aNSCLC or mNSCLC) approach treatment decision-making,...
New research presented at the...
03/28/2025
Journal of Clinical Pathways
Houda Hachad, PharmD
Interview
FDA Highlights Risks Associated With DPD Deficiency, Advises Testing Before Treatment
03/26/2025
Houda Hachad, PharmD
This interview explores the US Food and Drug Administration’s (FDA) updated guidance on dihydropyrimidine dehydrogenase (DPD) deficiency and its implications for improving patient safety through pre-treatment DPYD testing before...
This interview explores the US Food and Drug Administration’s (FDA) updated guidance on dihydropyrimidine dehydrogenase (DPD) deficiency and its implications for improving patient safety through pre-treatment DPYD testing before...
This interview explores the US...
03/26/2025
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use